Biopharmaceutical company Endocyte Inc said on Thursday that Novartis AG will acquire Endocyte in an all-cash deal for $24 per share, or a total equity value of about $2.1 billion.

https://ift.tt/2yKGVJw support@endlesssupplies.biz (Endless Supplies .Biz) October 18, 2018 at 01:03AM
No comments:
Post a Comment